Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Pediatr Hematol Oncol ; 44(1): e282-e286, 2022 01 01.
Artículo en Inglés | MEDLINE | ID: mdl-33930009

RESUMEN

Leukopenia, thrombocytopenia, elevated D-dimer, and prolonged prothrombin time are considered poor prognostic factors in adults with acute Coronavirus Disease 2019. The prognostic significance of these abnormalities among pediatric patients remains underreported in the literature. This retrospective cohort study evaluates the prognostic implications of hematologic and hemostatic derangements in patients younger than 22-years-of-age who were admitted to a tertiary-care referral institution for management of acute Coronavirus Disease 2019 infection. Leukopenia and thrombocytopenia were identified as independent prognostic factors of disease severity. Although the majority of children, with available results, had elevated D-dimer or prolonged prothrombin time upon initial presentation, these markers were not found to be associated with the development of severe clinical complications.


Asunto(s)
COVID-19/sangre , Hemostasis , Adolescente , Adulto , COVID-19/complicaciones , COVID-19/diagnóstico , Niño , Preescolar , Femenino , Productos de Degradación de Fibrina-Fibrinógeno/análisis , Humanos , Lactante , Leucopenia/sangre , Leucopenia/complicaciones , Leucopenia/diagnóstico , Masculino , Pronóstico , Estudios Retrospectivos , SARS-CoV-2/aislamiento & purificación , Índice de Severidad de la Enfermedad , Trombocitopenia/sangre , Trombocitopenia/complicaciones , Trombocitopenia/diagnóstico , Adulto Joven
2.
Am J Transplant ; 21(11): 3524-3537, 2021 11.
Artículo en Inglés | MEDLINE | ID: mdl-34008325

RESUMEN

Mesenchymal stem cells (MSC) have been shown to be immunomodulatory, tissue regenerative, and graft promoting; however, several questions remain with regard to ideal MSC source and timing of administration. In this study, we utilized a rigorous preclinical model of allogeneic islet cell transplantation, incorporating reduced immune suppression and near to complete mismatch of major histocompatibility antigens between the diabetic cynomolgus monkey recipient and the islet donor, to evaluate both the graft promoting impact of MSC source, that is, derived from the islet recipient, the islet donor or an unrelated third party as well as the impact of timing. Co-transplant of MSC and islets on post-operative day 0, followed by additional IV MSC infusions in the first posttransplant month, resulted in prolongation of rejection free and overall islet survival and superior metabolic control for animals treated with recipient as compared to donor or third-party MSC. Immunological analyses demonstrated that infusion of MSC from either source did not prevent alloantibody formation to the islet or MSC donor; however, treatment with recipient MSC resulted in significant downregulation of memory T cells, decreased anti-donor T cell proliferation, and a trend toward increased Tregulatory:Tconventional ratios.


Asunto(s)
Trasplante de Islotes Pancreáticos , Células Madre Mesenquimatosas , Aloinjertos , Animales , Macaca fascicularis , Trasplante Homólogo
3.
J Pediatr Hematol Oncol ; 43(5): e707-e710, 2021 07 01.
Artículo en Inglés | MEDLINE | ID: mdl-32555033

RESUMEN

Nuclear protein in testis carcinoma is a rare and highly aggressive carcinoma associated with a 70% mortality rate 1 year from diagnosis and a median survival of only 6.5 months. No established treatment protocol exists, although some success has been achieved using a multimodal approach including early surgical resection and adjuvant chemotherapy and radiation. Prior studies have not demonstrated successful treatment in the absence of upfront surgical resection. We describe the first reported case of a patient with unresectable nuclear protein in testis carcinoma treated successfully with definitive chemotherapy using the Scandinavian Sarcoma Group IX Protocol and concurrent radiation therapy, but without surgical resection.


Asunto(s)
Carcinoma/tratamiento farmacológico , Carcinoma/radioterapia , Proteínas de Neoplasias/genética , Proteínas Nucleares/genética , Adolescente , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Carcinoma/genética , Femenino , Humanos , Resultado del Tratamiento
4.
BMJ Case Rep ; 13(9)2020 Sep 08.
Artículo en Inglés | MEDLINE | ID: mdl-32907870

RESUMEN

This case aims to remind all providers to scrutinise for atypical presentations of multisystem inflammatory syndrome in children (MIS-C) which may mimic a more routine diagnosis. In the absence of mucocutaneous symptoms, the diagnosis of MIS-C can be missed. Given the potential for rapid deterioration of patients with MIS-C, early treatment and inpatient interventions are necessary.


Asunto(s)
Dolor Abdominal/inmunología , COVID-19/diagnóstico , Fiebre/inmunología , SARS-CoV-2/aislamiento & purificación , Síndrome de Respuesta Inflamatoria Sistémica/diagnóstico , Taquicardia/inmunología , Dolor Abdominal/sangre , Dolor Abdominal/terapia , Dolor Abdominal/virología , Adenosina Monofosfato/análogos & derivados , Adenosina Monofosfato/uso terapéutico , Alanina/análogos & derivados , Alanina/uso terapéutico , Proteína C-Reactiva/análisis , COVID-19/sangre , COVID-19/inmunología , COVID-19/terapia , Prueba de Ácido Nucleico para COVID-19 , Prueba Serológica para COVID-19 , Niño , Diagnóstico Diferencial , Fiebre/sangre , Fiebre/terapia , Fiebre/virología , Humanos , Proteína Antagonista del Receptor de Interleucina 1/uso terapéutico , Intubación Intratraqueal , Masculino , Síndrome Mucocutáneo Linfonodular/diagnóstico , Miocarditis/diagnóstico , Nasofaringe/virología , Péptido Natriurético Encefálico/sangre , SARS-CoV-2/inmunología , Síndrome de Respuesta Inflamatoria Sistémica/sangre , Síndrome de Respuesta Inflamatoria Sistémica/inmunología , Síndrome de Respuesta Inflamatoria Sistémica/terapia , Taquicardia/sangre , Taquicardia/terapia , Taquicardia/virología , Resultado del Tratamiento , Tratamiento Farmacológico de COVID-19
5.
Sci Immunol ; 5(49)2020 07 03.
Artículo en Inglés | MEDLINE | ID: mdl-32620562

RESUMEN

Engineered camelid antibody multimers can potently block SARS-CoV-2 viral entry.


Asunto(s)
Anticuerpos Antivirales , Infecciones por Coronavirus , Pandemias , Neumonía Viral , Coronavirus Relacionado al Síndrome Respiratorio Agudo Severo , Betacoronavirus , COVID-19 , Humanos , SARS-CoV-2
6.
ACG Case Rep J ; 7(3): e00338, 2020 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-32337304

RESUMEN

Appendiceal mucinous neoplasms are rarely diagnosed in pediatric patients. We present a 16-year-old adolescent boy with severe Crohn's disease who was not on maintenance medication for his underlying diagnosis. He was referred for nutritional optimization and small bowel obstruction. An emergent laparoscopic ileocecectomy with primary ileocolonic anastomosis was carried out secondary to acute peritonitis. Small bowel pathologic findings were consistent with Crohn's disease with low-grade appendiceal mucinous neoplasm (LAMN) of the appendix.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA